Notably, the PPARγ agonist 15-Deoxy-Δ12,14-prostaglandin J2 successfully inhibited cancer cell proliferation and promoted p21 mRNA expression in the Ishikawa, Sawano, and RL95-2 endometrial carcinoma cell lines [42]. This evidence concerns the gene PPARG and endometrial carcinoma.